Furthermore, interactions between cathepsins and other biomarkers, as well as genetic variabilities such as apolipoprotein E and Brain-Derived Neurotrophic Factor (BDNF), may contribute to the risk of Parkinson’s disease. Here, CTSS is linked to Parkinson disease.